Sarah Js Glickman is of 2seventy bio, Inc.. Currently has a direct ownership of 27,652 shares of TSVT, which is worth approximately $86,827. The most recent transaction as insider was on Jun 10, 2024, when has been sold 12,050 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.7K
0% 3M change
77.23% 12M change
Total Value Held $86,827

Sarah JS Glickman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2024
BUY
Grant, award, or other acquisition
-
12,050 Added 30.35%
27,652 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
8,400 Added 35.0%
15,602 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
4,200 Added 36.84%
7,202 Common Stock
Nov 11 2021
BUY
Grant, award, or other acquisition
-
3,002 Added 50.0%
3,002 Common Stock

Also insider at

CRTO
Criteo S.A. Communication Services
BLUE
bluebird bio, Inc. Healthcare
ATR
APTARGROUP, INC. Healthcare
SJG

Sarah Js Glickman

New York, NY

Track Institutional and Insider Activities on TSVT

Follow 2seventy bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSVT shares.

Notify only if

Insider Trading

Get notified when an 2seventy Bio, Inc. insider buys or sells TSVT shares.

Notify only if

News

Receive news related to 2seventy bio, Inc.

Track Activities on TSVT